GSK wins legal case over withdrawal effects of paroxetine after …
WEBJul 10, 2020 · A group action in the High Court in London by scores of claimants over withdrawal problems with the antidepressant paroxetine has ended in a victory for the manufacturer, GlaxoSmithKline (GSK), 13 years after the case was first launched. 1
Discontinuation of antidepressant could affect tapering patients, …
WEBJul 27, 2022 · The liquid selective serotonin reuptake inhibitor (SSRI) paroxetine (Seroxat; GSK) 20mg/10mL oral suspension is to be discontinued, raising concerns for patients in the process of tapering off the drug.
WEBBlockbuster antidepressant paroxetine is no stranger to headlines. The drug is now back centre stage as requests for clinical data from one of its trials are testing its manufacturer’s
Paroxetine - Wikipedia
WEBParoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat various disorders, such as depression, anxiety, and menopausal symptoms. It is sold under many brand names, such as Paxil and Seroxat, and has some common and serious side effects.
Indemnity costs award for GSK in long-running Seroxat litigation ...
WEBIndemnity costs award for GSK in long-running Seroxat litigation. Sandra Bailey & others v GlaxoSmithKline UK Limited [2020] EWHC 1766 (QB) Summary. On 3 July 2020, Lambert J handed down judgment in the High Court in the Seroxat Group Litigation, bringing to an end 13 years of litigation on the substantive issues.
GSK is sued in US over alleged link of paroxetine to birth defects
WEBOct 12, 2009 · GlaxoSmithKline (GSK) is facing the first of about 600 US lawsuits claiming that its antidepressant paroxetine (marketed as Paxil in the United States and Seroxat in the United Kingdom) caused birth defects in infants born to …
WEBThe Seroxat group action concerns a very widely used selective serotonin re- uptake inhibitor (“SSRI”) anti-depressant and anxiolytic medicine, manufactured by GSK.
GSK wins legal case over withdrawal effects of paroxetine after …
WEBJul 10, 2020 · GSK wins legal case over withdrawal effects of paroxetine after 13 years and £9.33m in costs. BMJ. 2020 Jul 10;370:m2799. doi: 10.1136/bmj.m2799.
AG Court of Appeal win In GSK Seroxat case - Addleshaw Goddard
WEBOn 8 November 2019, the English Court of Appeal handed down judgment in favour of GlaxoSmithKline (GSK) on the permitted scope of the long-running Seroxat litigation. Sandra Bailey & Others v GlaxoSmithKline UK Limited.
BBC and GSK battle over seroxat | News | Chemistry World
WEBJan 30, 2007 · UK pharmaceutical giant GlaxoSmithKline, which has spent the past few years fighting off accusations of risks associated with its market-leading antidepressant Seroxat, has rejected fresh claims that it improperly withheld …
Skip to content